SCI时时刷

search
+
Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry
Background . In the VICTORIA trial, vericiguat reduced the risk of cardiovascular mortality and hear...
Use of Outpatient Intravenous Calcitropes for Heart Failure in the United States
Rationale Outpatient calcitrope infusions—i.e., cardiac inotropes milrinone and dobutamine—are often...
Biomarker Testing Considerations in the Evaluation and Management of Patients with Heart Failure: Perspectives from the International Federation of Clinical Chemistry and Laboratory Medicine Committee
Emergency Department, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, U...
Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review
Sarcoidosis, or Besnier-Boeck-Schaumann Disease: The Frank Billings Lecture.JAMA. 117: 1321-1327Baughman RP Lower EE du Bo...
Picking up the Pieces of a Shattered Dream
It was May 2020, and less than a week had passed since the murder of George Floyd. I read the messages that close fr...
Iron Deficiency as a Potential Modulator of Subclinical Deficiencies in Cardiac Performance and Exercise Capacity
Yancy Clyde W. Jessup Mariell Bozkurt Biykem Butler J Casey Jr, DE Colvin MM et al.2017 ACC/AHA/HFSA focused update of the...
Cultivating Interest in Heart Failure Careers: Can We Reverse the Current Trend?
Nosheen RezaCorrespondenceReprint requests: Nosheen Reza MD, Division of Cardiovascular Medicine, Department of Medicine, ...
The International EMB Position Paper: A basis for integration into modern clinical practice
Recent years have seen the increase in global, multi-society consensus driven Guidelines and Position Papers. These ...
The Traditional Endomyocardial Biopsy: Opportunities to Rethink its Role as the Gold Standard
The evolution in device optimization and technique modification to the endomyocardial biopsy (EMB) procedure over ma...
nAddendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging
There are two primary reasons for an addendum. The first is that the document reviewer list is being updated to incl...
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial
Background The prediction of outcomes in patients with heart failure (HF) may inform prognosis, clin...
US Nationwide Prescription Fill Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic
AbstractBackgroundMaintaining a steady medication supply during a public health crisis is a major health priority. We leve...
Comparison of soluble ST2, pentraxin-3, galectin-3, and high-sensitivity troponin T of cardiovascular outcomes in patients with acute decompensated heart failure
Bettencourt P Azevedo A Pimenta J Frioes F Ferreira S Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcom...
Clinical Utility of Overlap Time for Incomplete Relaxation to Predict Cardiac Events in Heart Failure: Incomplete relaxation in heart failure
Background : The overlap time of transmitral flow can be a novel marker of subclinical left ventricular ...
Active BNP Measured by Mass Spectrometry and Response to Sacubitril/Valsartan
Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University School of Medicine, Nashville,...
Drugs of Abuse and Heart Failure
Heart disease and stroke Statistics-2019 update a report from the.American Heart Association. ()Forecasting the impact of...
On Leadership—A Call to Action for Aspirational Leadership Development for Programs Supporting Patients with Heart Failure
Andrew J. SauerCorrespondenceCorresponding author: Division of Advanced Heart Failure Therapies and Cardiac Transplantatio...
Treatment Effects of Sacubitril/Valsartan Compared With Valsartan in Patients with Recent Hospitalization
The Prospective Comparison of ARNI with ARB Global Outcomes in HF with Preserved Ejection Fraction (PARAGON-HF) tria...
Racial and Ethnic Disparities Persist in the Current Era of Pediatric Heart Transplantation
Background : Older studies demonstrated that children in the U.S. from racial and ethnic minorities ...
Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure
KeywordsTwo decades ago, the nascent field of left ventricular assist devices (LVADs) encountered a paradigm shift. The ol...
Patient Referral Practices to Advanced Heart Failure Centers
Background AHF therapies improve survival in a growing population of Stage D HF patients. Successful ...
Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action from the HELP Trial
Levosimendan is a K+-ATPase activator, cardiac myofilament Ca2+-sensitizer, and phosphodiesterase inhibitor with positive ...
Older Patients with Acute Decompensated Heart Failure Who Live Alone: An Analysis from the REHAB-HF Trial
Background We assessed the prevalence and clinical characteristics of patients with acute decompensated ...
"I've had a good run"
Patients with HF who we take care of over many years don't exactly become "friends", but mutual bonds do form that t...
Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Advanced Heart Failure Patients: A Single-Center Experience
Background Many patients with ACC/AHA Stage D (advanced) HF are discharged home on chronic intravenous ...
Combination Biomarkers for Risk Stratification in Patients with Chronic Heart Failure Biomarkers Prognostication in HF
Background Current guidelines recommend measuring natriuretic peptide biomarkers to establish progno...
Safety of Contemporary Heart Failure Therapy in Patients with Continuous-Flow Left Ventricular Assist Devices
Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Augustenburger Platz 1, 13353 Berlin, Germa...
PRESENCE OF INTRACARDIAC THROMBUS AT THE TIME OF LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION IS ASSOCIATED WITH INCREASED RISK OF STROKE AND DEATH
Background Heart failure predisposes to intracardiac thrombus (ICT) formation. There is limited data...
Selfcare Management Intervention in Heart Failure (SMART-HF) -A multicentre randomized controlled trial
AbstractBackgroundSelf-care behaviour is important in avoiding hospitalization for patients with heart failure (HF) and re...
Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid Sparing Agent
The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment.Chest. 2018; 153: 1432-1442Baughman RP Teirstein ...
阅读更多
format_indent_increase